tiprankstipranks
Trending News
More News >
Molecular Partners AG (CH:MOLN)
:MOLN
Switzerland Market

Molecular Partners AG (MOLN) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

MOLN Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Molecular
Partners AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MOLN Stock 12 Month Forecast

There Are No Analyst Ratings for CH:MOLN In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

MOLN Financial Forecast

MOLN Earnings Forecast

The previous quarter’s earnings for MOLN were -CHF0.34.
The previous quarter’s earnings for MOLN were -CHF0.34.

MOLN Sales Forecast

Currently, no sales data available.
Currently, no sales data available.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:MOLN
J.P. Morgan
J.P. Morgan
CHF4CHF3
Hold
-12.02%
Downside
Reiterated
12/08/25
Molecular Partners price target lowered to $3.75 from $4 at JPMorganMolecular Partners price target lowered to $3.75 from $4 at JPMorgan
TD Cowen
CHF15
Buy
339.88%
Upside
Reiterated
08/26/25
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on CH:MOLN
J.P. Morgan
J.P. Morgan
CHF4CHF3
Hold
-12.02%
Downside
Reiterated
12/08/25
Molecular Partners price target lowered to $3.75 from $4 at JPMorganMolecular Partners price target lowered to $3.75 from $4 at JPMorgan
TD Cowen
CHF15
Buy
339.88%
Upside
Reiterated
08/26/25
Promising Developments and Strategic Resource Management Justify Buy Rating for Molecular Partners AG
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Molecular Partners AG

3 Months
xxx
Success Rate
1/4 ratings generated profit
25%
Average Return
-0.40%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -0.40% per trade.
1 Year
Success Rate
1/4 ratings generated profit
25%
Average Return
-32.92%
a rating ―
Copying Michael Nedelcovych's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -32.92% per trade.
2 Years
xxx
Success Rate
0/4 ratings generated profit
0%
Average Return
-47.40%
a xxx
rating ―
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -47.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MOLN Analyst Recommendation Trends

Rating
Nov 25
Dec 25
Jan 26
Feb 26
Mar 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
1
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
1
1
1
0
In the current month, MOLN has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. MOLN average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

MOLN Stock Forecast FAQ

What is CH:MOLN’s average 12-month price target, according to analysts?
Currently, no data Available
What is CH:MOLN’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:MOLN, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Molecular Partners AG a Buy, Sell or Hold?
      Currently, no data Available
      What is Molecular Partners AG’s share price target?
      Currently, no data Available
      What do analysts say about Molecular Partners AG?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Molecular Partners AG?
      To buy shares of CH:MOLN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.